Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xin-xin Cao, Shu-hua Yi, Zhong-xing Jiang, Jing-song He, Wei Yang, Juan Du, Chun-yan Sun, Yu Wu, Wen-ming Chen, Xiao-jun Liu, Bing-zong Li, Chun-rui Li, Wei Sang, Qin-hua Liu, Xiao-xia Chu, Fei Li, Ou Bai, Min Mao, Rong Fu, Wei Wang, Li-hong Liu, Lu-qun Wang, Yu-jun Dong, Jun Luo, Zhen-ling Li, Yong-qiang Wei, Qi-ke Zhang, Jing Liu, Kai-yang Ding, Liang Zou, Bi-yun Chen, Luo-ming Hua, Hong-mei Jing, Juan He, Liang Wang, Jian Li & Lu-gui Qiu. (2021) Treatment and outcome patterns of patients with Waldenström’s macroglobulinemia: a large, multicenter retrospective review in China. Leukemia & Lymphoma 62:11, pages 2657-2664.
Read now
Read now
Ilyas Sahin, Houry Leblebjian, Steven P Treon & Irene M Ghobrial. (2014) Waldenström macroglobulinemia: from biology to treatment. Expert Review of Hematology 7:1, pages 157-168.
Read now
Read now
Stefan Peinert & John F. Seymour. (2010) Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia. Leukemia & Lymphoma 51:10, pages 1767-1770.
Read now
Read now
Morie A. Gertz. (2010) What's new in Waldenström macroglobulinemia. Leukemia & Lymphoma 51:10, pages 1765-1766.
Read now
Read now
Articles from other publishers (14)
Richard Lemal, Stéphanie Poulain, Albane Ledoux‐Pilon, Lauren Veronese, Andrei Tchirkov, Benjamin Lebecque, Thomas Tassin, Jacques‐Olivier Bay, Frédéric Charlotte, Florence Nguyen‐Khac, Marc Berger, Catherine Godfraind, Loïc Ysebaert, Frédéric Davi, Bruno Pereira, Véronique Leblond, Olivier Hermine, Romain Guièze, Franck Pagès & Olivier Tournilhac. (2022) Mast cell density and its clinical relevance in Waldenström's macroglobulinemia. eJHaem 3:2, pages 371-378.
Crossref
Crossref
Christian Buske, Shalal Sadullah, Efstathios Kastritis, Alessandra Tedeschi, Ramón García-Sanz, Lukasz Bolkun, Xavier Leleu, Wolfgang Willenbacher, Roman Hájek, Monique C Minnema, Mei Cheng, Elizabeth Bilotti, Thorsten Graef & Meletios A Dimopoulos. (2018) Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review. The Lancet Haematology 5:7, pages e299-e309.
Crossref
Crossref
Meletios A. DimopoulosAlessandra TedeschiJudith TrotmanRamón García-SanzDavid MacdonaldVeronique LeblondBeatrice MaheCharles HerbauxConstantine TamLorella OrsucciM. Lia PalombaJeffrey V. MatousChaim ShustikEfstathios KastritisSteven P. TreonJianling LiZeena SalmanThorsten GraefChristian Buske. (2018) Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia. New England Journal of Medicine 378:25, pages 2399-2410.
Crossref
Crossref
Richard Lemal, Sandrine Bard-Sorel, Laura Montrieul, Jacques-Olivier Bay, Aurélie Ravinet, Albane Ledoux-Pilon, Nicolas Cagnard, Sébastien Bailly, Pierre Morel, Frédéric Charlotte, Xavier Leleu, Stéphanie Poulain, Pierre J Déchelotte, Olivier Hermine, Véronique Leblond, Olivier Tournilhac & Romain Guièze. (2016) TCL1 expression patterns in Waldenström macroglobulinemia. Modern Pathology 29:1, pages 83-88.
Crossref
Crossref
G Palladini, P Milani, A Foli, M Vidus Rosin, M Basset, F Lavatelli, M Nuvolone, L Obici, S Perlini & G Merlini. (2014) Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients. Leukemia 28:12, pages 2311-2316.
Crossref
Crossref
Federico CampigottoEdie Weller. (2014) Impact of Informative Censoring on the Kaplan-Meier Estimate of Progression-Free Survival in Phase II Clinical Trials. Journal of Clinical Oncology 32:27, pages 3068-3074.
Crossref
Crossref
Leonard T HeffnerJrJr. (2014) Waldenström macroglobulinemia at 70. International Journal of Hematologic Oncology 3:4, pages 253-266.
Crossref
Crossref
Ewelina Wawryk-Gawda, Patrycja Chylińska-Wrzos, Marta Lis-Sochocka, Kamila Bulak & Barbara Jodłowska-Jędrych. (2014) Intrinsic Apoptosis Pathway in Fallopian Tube Epithelial Cells Induced by Cladribine. The Scientific World Journal 2014, pages 1-9.
Crossref
Crossref
Marian Jędrych, Ewelina Wawryk-Gawda, Barbara Jodłowska-Jędrych, Patrycja Chylińska-Wrzos & Ludwik Jasiński. (2013) Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats. Protoplasma 250:5, pages 1025-1034.
Crossref
Crossref
Houry Leblebjian, Amit Agarwal & Irene Ghobrial. (2013) Novel Treatment Options for Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma and Leukemia 13, pages S310-S316.
Crossref
Crossref
Irene M. GhobrialFederico CampigottoTimothy J. Murphy, Erica N. BoswellRanjit BanwaitFeda AzabStacey ChumaJanet KunsmanAmanda DonovanFarzana MasoodDiane WarrenScott Rodig, Kenneth C. AndersonPaul G. RichardsonEdie WellerJeffrey Matous. (2013) Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia. Blood 121:8, pages 1296-1303.
Crossref
Crossref
. 2013. Ferri's Clinical Advisor 2013. Ferri's Clinical Advisor 2013
1166
1177
.
V Bachanova & L J Burns. (2011) Hematopoietic cell transplantation for Waldenström macroglobulinemia. Bone Marrow Transplantation 47:3, pages 330-336.
Crossref
Crossref
Ghayas C Issa, Houry Leblebjian, Aldo M Roccaro & Irene M Ghobrial. (2011) New insights into the pathogenesis and treatment of Waldenstrom macroglobulinemia. Current Opinion in Hematology 18:4, pages 260-265.
Crossref
Crossref